628 related articles for article (PubMed ID: 15946424)
1. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
2. Obesity surgery and the role in treating type 2 diabetes mellitus, are we ready for the next step?
Abbas SM
Curr Surg; 2006; 63(2):92-5; quiz 95-6. PubMed ID: 16520107
[No Abstract] [Full Text] [Related]
3. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
4. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
[TBL] [Abstract][Full Text] [Related]
5. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
6. Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients.
Czupryniak L; Strzelczyk J; Pawlowski M; Loba J
Obes Surg; 2004; 14(10):1393-7. PubMed ID: 15603657
[TBL] [Abstract][Full Text] [Related]
7. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
8. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
9. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a non-superobese population.
Kalfarentzos F; Skroubis G; Kehagias I; Mead N; Vagenas K
Obes Surg; 2006 Feb; 16(2):151-8. PubMed ID: 16469216
[TBL] [Abstract][Full Text] [Related]
10. Totally robotic Roux-en-Y gastric bypass.
Mohr CJ; Nadzam GS; Curet MJ
Arch Surg; 2005 Aug; 140(8):779-86. PubMed ID: 16103289
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after gastric bypass.
White S; Brooks E; Jurikova L; Stubbs RS
Obes Surg; 2005 Feb; 15(2):155-63. PubMed ID: 15802056
[TBL] [Abstract][Full Text] [Related]
12. Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population undergoing laparoscopic Roux-en-Y gastric bypass.
Perugini RA; Li Y; Rosenthal L; Gallagher-Dorval K; Kelly JJ; Czerniach DR
Surg Obes Relat Dis; 2010; 6(3):237-41. PubMed ID: 20005785
[TBL] [Abstract][Full Text] [Related]
13. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
[TBL] [Abstract][Full Text] [Related]
14. Revision of failed laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass.
van Wageningen B; Berends FJ; Van Ramshorst B; Janssen IF
Obes Surg; 2006 Feb; 16(2):137-41. PubMed ID: 16469213
[TBL] [Abstract][Full Text] [Related]
15. Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass.
Ramos AP; de Abreu MR; Vendramini RC; Brunetti IL; Pepato MT
Obes Surg; 2006 Oct; 16(10):1359-64. PubMed ID: 17059747
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms of surgical treatment of type 2 diabetes.
Mason EE
Obes Surg; 2005 Apr; 15(4):459-61. PubMed ID: 15946422
[No Abstract] [Full Text] [Related]
17. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.
Zervos EE; Agle SC; Warren AJ; Lang CG; Fitzgerald TL; Dar M; Rotondo MF; Pories WJ
J Am Coll Surg; 2010 May; 210(5):564-72, 572-4. PubMed ID: 20421005
[TBL] [Abstract][Full Text] [Related]
19. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial.
Alami RS; Morton JM; Schuster R; Lie J; Sanchez BR; Peters A; Curet MJ
Surg Obes Relat Dis; 2007; 3(2):141-5; discussion 145-6. PubMed ID: 17331803
[TBL] [Abstract][Full Text] [Related]
20. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.
Pinheiro JS; Schiavon CA; Pereira PB; Correa JL; Noujaim P; Cohen R
Surg Obes Relat Dis; 2008; 4(4):521-5; discussion 526-7. PubMed ID: 18539540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
